Try our mobile app

General information

Country: UNITED STATES

Sector: Diagnostics and Research

Thermo Fisher Scientific, Inc. manufactures scientific instruments, consumables, and chemicals. The Company offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies.
Website: thermofisher.com


  • Pretty weak financial results growth rate 1.2% (average between last period year over year growth for revenue and EBITDA), there is acceleration compared to average historical growth rates (-0.7%)
  • Dividend yield for the last twelve months 0.4%
  • Free cash flow yield -0.8% (LTM)
  • Share price is 1.7% higher than minimum and 35.8% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (16.1x vs
    )
  • Fundamental value created in LTM (estimate)
  • For the last 3 months insiders sold company shares on $2.3 mln (-0.001% of cap.)

Key Financials (Download financials)

Ticker: TMO
Share price, USD:  (-0.8%)400.45
year average price 536.20  


year start price 579.84 2024-06-06

max close price 624.21 2024-09-10

min close price 393.66 2025-05-23

current price 400.81 2025-06-05
Common stocks: 391 000 000

Dividend Yield:  0.4%
FCF Yield LTM: -0.8%
EV / LTM EBITDA: 16.1x
EV / EBITDA annualized: 19.1x
Last revenue growth (y/y):  +0.2%
Last growth of EBITDA (y/y):  +2.3%
Historical revenue growth:  +1.8%
Historical growth of EBITDA:  -3.2%
Target EV / EBITDA (hist percentile):
Express share price potential:
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 156 576
Net Debt ($m): -5 849
EV (Enterprise Value): 150 727
EBITDA LTM ($m): 9 369
EV / LTM EBITDA: 16.1x
Price to Book: 3.2x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2025-06-03zacks.com

TMO Launches Next-Generation Mass Spectrometers: Stock to Gain?

2025-06-02seekingalpha.com

Thermo Fisher: With A 30% Price Drop, Trump Legislation, And High Capex, Is It Undervalued?

2025-06-01seekingalpha.com

Thermo Fisher Is Strengthening Its Long-Term Advantage

2025-05-30zacks.com

Thermo Fisher Launches New Spectral Flow Cytometer: Stock to Gain?

2025-05-26zacks.com

TMO Stock Set to Gain From the Launch of New Narcotic Analyzers

2025-05-12seekingalpha.com

Thermo Fisher: Tariffs Hit, Valuation Compensates

2025-04-16zacks.com

Robust Specialty Diagnostics Segment Likely to Aid TMO's Q1 Earnings

2025-04-14seekingalpha.com

Thermo Fisher Scientific And Its Real Value

2025-04-10zacks.com

Thermo Fisher (TMO) Surges 8.2%: Is This an Indication of Further Gains?

2025-04-02zacks.com

Is it Worth Retaining Thermo Fisher Stock in Your Portfolio Now?
More information for subscribed users:
detailed calculation of
Potential and Created Value,
website traffic data